Offer - Urjas Oil for just ₹ 1
Celginase 5000 Injection is a prescription drug, available for use as Injection. It is primarily used for the treatment of Blood Cancer.
Medical history of the patient along with age and gender determines the dosage of Celginase 5000 Injection. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
The side effects typically associated with Celginase 5000 Injection include Rash, Nausea or vomiting, Increased Liver Enzymes. These side effects of Celginase 5000 Injection are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
Celginase 5000 Injection's effect during pregnancy is Moderate and Severe while nursing. In addition, Celginase 5000 Injection's effects on the liver, heart and kidney are discussed below in the Celginase 5000 Injection related warnings section.
Celginase 5000 Injection is not recommended if you suffer from certain medical conditions as it can have adverse effects. Bleeding, Pancreatitis are examples of such conditions. Other conditions have been mentioned below in the Celginase 5000 Injection contraindications section.
Drug reaction of Celginase 5000 Injection with other medicines has been reported. A complete list of these interactions is given below.
In addition to the above precautions for Celginase 5000 Injection, it is important to know that it is not safe while driving, and is not habit-forming.
Celginase 5000 Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Celginase 5000 Injection safe for pregnant women?
Pregnant women may experience moderate side effects from Celginase. It is best to stop taking Celginase immediately and inform your doctor if you notice any discomfort.
Is the use of Celginase 5000 Injection safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Celginase. So it is adviced to consult the doctor before using it.
What is the effect of Celginase 5000 Injection on the Kidneys?
Very few cases of side effects of Celginase on kidney have been reported.
What is the effect of Celginase 5000 Injection on the Liver?
There may be an adverse effect on the liver after taking Celginase. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Celginase 5000 Injection on the Heart?
Celginase is not harmful for the heart.
If you are suffering from any of the following diseases, you should not take Celginase 5000 Injection unless your doctor advises you to do so -
Is this Celginase 5000 Injection habit forming or addictive?
No, you will not get addicted to Celginase 5000 Injection.
Is it safe to drive or operate heavy machinery when consuming?
After taking Celginase 5000 Injection you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, but consume Celginase 5000 Injection only on doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Celginase 5000 Injection for mental disorders.
Interaction between Food and Celginase 5000 Injection
Taking Celginase 5000 Injection with food does not harm your health.
Interaction between Alcohol and Celginase 5000 Injection
No research has been done on this till date. Therefore, it is not known what the effect of taking Celginase 5000 Injection with alcohol will be.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Elspar® (Asparaginase)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 868-869
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 190-191